DRUG DISCOVERY PRODUCTS & SERVICES

  • Whether you are ramping up for clinical trials or preparing for large-scale GMP production, explore a variety of options tailored for a complete mAb process, available at both pilot and production scales.

  • Learn about a combination of high-performing raw materials, advanced synthetic transfection reagents, and chemically defined HEK media that can overcome the challenges of commercial-scale production.

  • Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.

  • Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.

  • Can my product be NanoImproved? Find out at at-a-glance with a brand new Nanoform 4-page informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.

  • Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

  • Process Trains For Flexible, Configurable Biopharma Manufacturing Capacity
    9/16/2024

    Transform your space to fit your needs

    Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan your agile manufacturing strategy with greater efficiency and integration to address current and future capacity needs.

  • Nitrosamine Capabilities
    8/22/2024

    Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology to boost your drug product development.

  • Expediting Drug Discovery From Concept To Commercialization
    8/13/2024

    Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.

  • ELEVECTA™ Producer Cell Line For Stable, Inducible AAV Production
    8/8/2024

    ELEVECTA™ producer cell line is a stable line for inducible adeno-associated virus (AAV) production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome, and it requires only a single induction step to initiate AAV production.

  • Allegro MVP Single-Use System
    8/6/2024

    Explore an automated bioprocessing system designed to enhance flexibility and boost productivity in both upstream and downstream single-use processes.

  • An Automated Filtration And Bulk Filling System
    8/6/2024

    Discover an automated filtration and filling system designed to accurately and aseptically aliquot bulk product into multiple biocontainers or bottles.

  • Single-Use Automated Virus Filtration System
    8/6/2024

    Learn about a single-use automated filtration system designed to deliver robust process control during this critical downstream step.

  • A Single-Use, Automated Depth Filtration System
    8/6/2024

    Single-use, automated filtration system designed to deliver robust process control during the clarification/harvest step.